Jill Anderson


Moses & Singer


Jill E. Anderson is a partner in the Healthcare and Privacy & CyberSecurity practice groups at Moses & Singer. She counsels emerging to late-stage biotechnology companies, medical device companies, patient advocacy groups, research foundations and institutes, biorepositories, research consortia and academic medical centers on regulatory and compliance issues related to product development and the privacy and security of data.

Jill has significant experience advising clients how to structure and implement research organizations, models, and strategic collaborations. She has drafted and negotiated hundreds of complex research agreements and plays a crucial role in identifying & mitigating regulatory and compliance risks related to research and development. She counsels clients on cutting-edge issues involving clinical and translational research including personalized medicine, therapeutics, diagnostics, genomics, proteomics, cell regeneration, biorepositories, research misconduct, fraud and abuse issues, anti-kickback laws and clinical trial disclosure and registration requirements.

Jill also provides strategic advice to a variety of healthcare clients on complex privacy and security issues related to data management including HIPAA and HITECH; data mining, electronic health record development and implementation; deployment of electronic health record systems, affiliations and joint ventures between healthcare providers and vendors who service providers. She counsels clients on how to preserve, protect and recover electronic research data as well as how to address potential and actual data security breaches and vulnerabilities.

Jill was formerly an attorney with Dana-Farber Cancer Institute and Partners Healthcare System (founded by Massachusetts General Hospital and Brigham and Women’s Hospital), where she focused on regulatory and compliance issues related to clinical research.

Law School Activities/Honors
Widener Law Symposium Journal
Member, Phi Delta Phi

“Regulatory Strategy and Revenue Generation for Life Sciences Startups,” Bio & Health Tech Entrepreneurship Lab, NYC Economic Development Corp., January 2014
Speaker, “Contracts and Legal Documents,” Bio & Health Tech Entrepreneurship Lab NYC, February 2013
Strafford Webinar, “Clinical Trials Compliance: Latest Regulatory and Enforcement Developments,” October 2012
Fordham University School of Law and Moses & Singer CLE Program, “Recent Developments in U.S. Law: Privacy and Information Technology,” July 2012
Drug Information Association Annual Meeting, “Best Practices in Clinical Trials,” June 2010

Professional Affiliations
American Health Lawyers Association, Life Sciences, and Academic Medical Centers/Teaching Hospitals

Practice Groups
Boston Bar Association, Health Law Section
Women Entrepreneurs in Science and Technology
Harvard Biotechnology Club
New York Biotechnology Association

Newsletter Signup

Corporate Supporters

Pfizer Logo

ELabNYC is a Program of

Initiated by